Pulmonx (LUNG) Change in Accured Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Accured Expenses data on file, last reported at $528000.0 in Q3 2025.

• On a quarterly basis, Change in Accured Expenses fell 27.87% year-over-year to $528000.0 in Q3 2025; TTM through Sep 2025 was $2.1 million, a 269.71% increase from a year earlier, with the FY2024 full-year figure at $462000.0, down 85.45% from the prior year.
• Change in Accured Expenses for Q3 2025 stood at $528000.0, down from $2.5 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for LUNG reached as high as $4.0 million in Q4 2024 and fell as low as -$6.0 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $355315.8 across 5 years, with a median of $1.0 million in 2022.
• Across the five-year window, Change in Accured Expenses jumped 237.32% in 2021 and tumbled 357.53% in 2022, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.5 million in 2021, then jumped by 58.05% to $2.4 million in 2022, then dropped by 5.53% to $2.3 million in 2023, then jumped by 76.48% to $4.0 million in 2024, then tumbled by 86.72% to $528000.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $528000.0 in Q3 2025, $2.5 million in Q2 2025, and -$4.9 million in Q1 2025.